Shi-Yong Sun is a Tenured Professor in the Department of Hematology and Medical Oncology in the Emory University School of Medicine and Winship Cancer Institute in Atlanta, Ga, USA. Dr. Sun earned his Ph.D. degree in cancer pharmacology in China and late received his postdoctoral training in cancer biology at The University of Texas MD Anderson Cancer Center in Houston, Tex, USA. Dr. Sun's research primarily focuses on the regulation of death receptors, particularly TRAIL receptors, by small therapeutic molecules and their implications in drug-induced apoptosis and cancer therapy. In addition, his lab is interested in understanding mTOR signaling in cancer and targeting the mTOR axis for cancer therapy. Dr. Sun is a recipient of a Georgia Cancer Coalition Distinguished Cancer Scholar Award and numerous peer-reviewed grant awards including NIH/NCI R01, P01, and SPORE. He is on the editorial boards of 17 cancer-related journals and has published extensively in prominent peer-reviewed journals such as Journal of the National Cancer Institute, Molecular and Cellular Biology, Cancer Research, Journal of Biological Chemistry, and Oncogene.
Biography Updated on 27 January 2013